James Quigley
Stock Analyst at Goldman Sachs
(0.15)
# 4,313
Out of 4,421 analysts
323
Total ratings
38%
Success rate
-9.5%
Average return
Main Sectors:
Stocks Rated by James Quigley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | kr 263.00 → kr 305.00 | $279.92 | +8.96% | 35 | Jun 4, 2026 | |
| NVO Novo Nordisk | Maintained: Hold | $41 → $47 | $43.19 | +8.82% | 9 | Jun 3, 2026 | |
| SWX: NOVN Novartis AG | Maintained: Sell | CHF 105.00 → CHF 106.00 | $118.04 | -10.20% | 25 | Apr 29, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Maintained: Hold | €232.00 → €230.00 | $217.10 | +5.94% | 29 | Apr 27, 2026 | |
| SWX: ROP Roche Holding AG | Maintained: Hold | CHF 349.00 → CHF 346.00 | $319.00 | +8.46% | 25 | Apr 24, 2026 | |
| EPA: DIM Sartorius Stedim Biotech S.A. | Maintained: Buy | €214.00 | $165.50 | +29.31% | 23 | Apr 23, 2026 | |
| ETR: BAYN Bayer Aktiengesellschaft | Maintained: Buy | €54.00 → €55.00 | $37.15 | +48.05% | 58 | Apr 20, 2026 | |
| ETR: MRK Merck KGaA | Maintained: Buy | €153.00 → €147.00 | $133.05 | +10.48% | 43 | Apr 16, 2026 | |
| EPA: SAN Sanofi | Maintained: Hold | €90.00 → €89.00 | $73.34 | +21.35% | 9 | Jan 30, 2026 | |
| SWX: LONN Lonza Group AG | Maintained: Buy | CHF 650.00 → CHF 670.00 | $491.60 | +36.29% | 21 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $49.74 | - | 1 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $121 → $118 | $147.08 | -19.77% | 3 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $867.50 | - | 1 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $65 → $60 | $42.38 | +41.58% | 2 | Jul 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | 15,200p | $13,154.00 | n/a | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €13.00 → €10.50 | $1.24 | n/a | 2 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €27.00 → €28.00 | $4.54 | n/a | 10 | Sep 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | CHF 65.00 → CHF 64.00 | $67.00 | n/a | 2 | Sep 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 38.00 → CHF 21.00 | $37.30 | n/a | 5 | Sep 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €38.00 → €36.00 | $24.58 | n/a | 2 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $15 | $2.56 | n/a | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €410.00 → €545.00 | $764.20 | n/a | 2 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | kr 1,950 → kr 2,235 | $1,614.50 | n/a | 7 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $140 → $205 | $28.32 | n/a | 2 | Jan 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $25.27 | n/a | 1 | Jun 20, 2018 |
Novo Nordisk A/S
Jun 4, 2026
Maintained: Hold
Price Target: kr 263.00 → kr 305.00
Current: $279.92
Upside: +8.96%
Novo Nordisk
Jun 3, 2026
Maintained: Hold
Price Target: $41 → $47
Current: $43.19
Upside: +8.82%
Novartis AG
Apr 29, 2026
Maintained: Sell
Price Target: CHF 105.00 → CHF 106.00
Current: $118.04
Upside: -10.20%
Sartorius Aktiengesellschaft
Apr 27, 2026
Maintained: Hold
Price Target: €232.00 → €230.00
Current: $217.10
Upside: +5.94%
Roche Holding AG
Apr 24, 2026
Maintained: Hold
Price Target: CHF 349.00 → CHF 346.00
Current: $319.00
Upside: +8.46%
Sartorius Stedim Biotech S.A.
Apr 23, 2026
Maintained: Buy
Price Target: €214.00
Current: $165.50
Upside: +29.31%
Bayer Aktiengesellschaft
Apr 20, 2026
Maintained: Buy
Price Target: €54.00 → €55.00
Current: $37.15
Upside: +48.05%
Merck KGaA
Apr 16, 2026
Maintained: Buy
Price Target: €153.00 → €147.00
Current: $133.05
Upside: +10.48%
Sanofi
Jan 30, 2026
Maintained: Hold
Price Target: €90.00 → €89.00
Current: $73.34
Upside: +21.35%
Lonza Group AG
Jan 29, 2026
Maintained: Buy
Price Target: CHF 650.00 → CHF 670.00
Current: $491.60
Upside: +36.29%
Jan 15, 2026
Upgraded: Hold
Price Target: n/a
Current: $49.74
Upside: -
Sep 12, 2025
Downgraded: Sell
Price Target: $121 → $118
Current: $147.08
Upside: -19.77%
Jul 30, 2025
Maintained: Hold
Price Target: n/a
Current: $867.50
Upside: -
Jul 3, 2025
Maintained: Hold
Price Target: $65 → $60
Current: $42.38
Upside: +41.58%
May 30, 2024
Initiated Coverage: Buy
Price Target: 15,200p
Current: $13,154.00
Upside: n/a
Oct 10, 2023
Maintained: Hold
Price Target: €13.00 → €10.50
Current: $1.24
Upside: n/a
Sep 25, 2023
Maintained: Buy
Price Target: €27.00 → €28.00
Current: $4.54
Upside: n/a
Sep 25, 2023
Maintained: Sell
Price Target: CHF 65.00 → CHF 64.00
Current: $67.00
Upside: n/a
Sep 25, 2023
Maintained: Hold
Price Target: CHF 38.00 → CHF 21.00
Current: $37.30
Upside: n/a
Sep 5, 2023
Maintained: Hold
Price Target: €38.00 → €36.00
Current: $24.58
Upside: n/a
Aug 8, 2023
Maintained: Buy
Price Target: $16 → $15
Current: $2.56
Upside: n/a
Jul 28, 2023
Maintained: Buy
Price Target: €410.00 → €545.00
Current: $764.20
Upside: n/a
May 12, 2023
Initiated Coverage: Sell
Price Target: kr 1,950 → kr 2,235
Current: $1,614.50
Upside: n/a
Jan 5, 2020
Downgraded: Hold
Price Target: $140 → $205
Current: $28.32
Upside: n/a
Jun 20, 2018
Upgraded: Buy
Price Target: n/a
Current: $25.27
Upside: n/a